Diamedica Therapeutics Inc (DMAC)

04:55 AM

The Beat: Entrust names new CEO, DiaMedica raises millions - The Business Journals

04:55 AM

01:13 AM

DiaMedica Therapeutics Announces Closing of $30.1 Million Private Placement - BioSpace

01:13 AM

Jul 23, 2025

DiaMedica Therapeutics Secures $30.1 Million in Private Placement - TipRanks

Jul 23, 2025

Jul 23, 2025

DiaMedica Therapeutics closes $30.1 million private placement - Investing.com India

Jul 23, 2025

Jul 22, 2025

Is DiaMedica Therapeutics Inc. a good long term investmentDynamic profit expansion - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

DiaMedica Therapeutics Inc. Stock Analysis and ForecastOutperformance with explosive growth - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What drives DiaMedica Therapeutics Inc. stock priceExtraordinary market timing - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What analysts say about DiaMedica Therapeutics Inc. stockFree Stock Market Knowledge Sharing - jammulinksnews.com

Jul 22, 2025

Jul 21, 2025

Diamedica Therapeutics shares rise 11.01% intraday after $30.1M private placement and positive trial results for DM199 in preeclampsia. - AInvest

Jul 21, 2025

Jul 21, 2025

DiaMedica Announces $30.1M Private Placement for DM199 - TipRanks

Jul 21, 2025

Jul 21, 2025

DiaMedica secures $30.1 million in private placement for clinical trials By Investing.com - Investing.com South Africa

Jul 21, 2025

Jul 21, 2025

DiaMedica secures $30.1 million in private placement for clinical trials - Investing.com

Jul 21, 2025

Jul 21, 2025

DiaMedica Therapeutics Raises $30 Million in Private Placement to Accelerate Industry Leading Preeclampsia and Fetal Growth Restriction Pipeline - Business Wire

Jul 21, 2025

Jul 21, 2025

DiaMedica Therapeutics (NASDAQ:DMAC) Price Target Raised to $12.00 - Defense World

Jul 21, 2025

Jul 20, 2025

DiaMedica shares drop 35% following InvestingPro’s overvalued warning By Investing.com - Investing.com India

Jul 20, 2025

Jul 19, 2025

DiaMedica gains on positive mid-stage trial data for lead drug in preeclampsia - MSN

Jul 19, 2025

Jul 18, 2025

What makes DiaMedica Therapeutics Inc. stock price move sharplyReliable High Profit Alerts - beatles.ru

Jul 18, 2025

Jul 18, 2025

DiaMedica stock price target raised to $12 from $10 at H.C. Wainwright - Investing.com

Jul 18, 2025

Jul 17, 2025

DiaMedica Therapeutics to be included in the Russell 2000 and 3000 indexes - MSN

Jul 17, 2025

Jul 17, 2025

DiaMedica Therapeutics Reports Positive Interim Phase 2 Preeclampsia Results: Statistically Significant Reductions in Blood Pressure and No Placental Transfer - BioSpace

Jul 17, 2025

Jul 17, 2025

DiaMedica Therapeutics reports interim results from DM199 study - TipRanks

Jul 17, 2025

Jul 17, 2025

DiaMedica Announces Positive Interim Results for DM199 Study - TipRanks

Jul 17, 2025

Jul 17, 2025

DiaMedica reports positive interim results for preeclampsia treatment - Investing.com

Jul 17, 2025

Jul 15, 2025

Why DiaMedica Therapeutics Inc. stock attracts strong analyst attentionVerified Return Tips - Newser

Jul 15, 2025

Jul 15, 2025

How DiaMedica Therapeutics Inc. stock performs during market volatilityValue Pick Scanner - Newser

Jul 15, 2025

Jul 15, 2025

3 Promising Penny Stocks With Market Caps Under $200M - simplywall.st

Jul 15, 2025

Jul 01, 2025

Trend Tracker for (DMAC) - news.stocktradersdaily.com

Jul 01, 2025

Jun 30, 2025

DiaMedica Therapeutics Inc.(NasdaqCM: DMAC) added to Russell 2000 Dynamic Index - MarketScreener

Jun 30, 2025

Jun 30, 2025

DiaMedica Therapeutics Inc.(NasdaqCM: DMAC) added to Russell 3000 Growth Index - MarketScreener

Jun 30, 2025

Jun 24, 2025

DiaMedica Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes - Business Wire

Jun 24, 2025

Jun 14, 2025

DiaMedica Therapeutics Insiders Up US$4.1m On US$9.00m Investment - simplywall.st

Jun 14, 2025

Jun 10, 2025

Millennium Management LLC Increases Holdings in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Defense World

Jun 10, 2025

Jun 05, 2025

42,212 Shares in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Purchased by Jane Street Group LLC - Defense World

Jun 05, 2025

Jun 04, 2025

Can DiaMedica Deliver A Breakthrough In Preeclampsia Treatment? - RTTNews

Jun 04, 2025

Jun 04, 2025

Short Interest in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Increases By 38.3% - Defense World

Jun 04, 2025

May 30, 2025

Lake Street Keeps Their Buy Rating on Diamedica Therapeutics (DMAC) - The Globe and Mail

May 30, 2025

May 30, 2025

Northern Trust Corp Has $978,000 Holdings in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Defense World

May 30, 2025

May 30, 2025

DMAC: HC Wainwright & Co. Reiterates Buy Rating with $10 Price T - GuruFocus

May 30, 2025